Skip to content
Fullscript leaf logo
Create account
Fullscript logo
Fullscript leaf logo
  • Solutions
    • Plan care
      Lab testing Offer end-to-end diagnostics.
      Supplement catalog Recommend healthcare’s best.
      Clinical decision support Optimize your patients’ plans.
      Evidence-based templates Build complete plans quickly.
    • Deliver care
      Online plans Send individual and multi-patient plans.
      Wholesale ordering Dispense supplements from your clinic.
    • Engage patients
      Patient experience See how patients thrive on Fullscript.
      Adherence & insights Keep patients on track with less effort.
      Patient promotions Offer savings, engage patients in a few clicks.
    • IntegrationsSee all integrations
  • Resources
    • Learn
      How to use Fullscript Explore quick demos, articles, and more.
      Wellness blog Education for practitioners and patients.
      Webinars 100+ recordings of practitioner discussions.
      Protocols Our library of evidence-based protocols.
      Clinical evidence Studies that support the Fullscript platform.
      Practice resources Handouts, promotional tools, and more.
      Ingredient library Decision support for supplement ingredients.
    • Featured
      lets make healthcare whole kyle feature image
      Let’s Make Healthcare Whole

      Learn how Fullscript is making whole person care more attainable, scalable, and impactful.

  • Pricing
Sign in Create account Book a demo Sign in
Research Update
—

Research Update: A Systematic Review and Meta-analysis of Herbal Treatment of Irritable Bowel Syndrome

Updated on March 24, 2022 | Published on July 14, 2021
Fact checked
Dr. Clara Sage Sartor, ND, BSc Avatar
Written by Dr. Clara Sage Sartor, ND, BSc
Dr. Christopher Knee, ND
Medically reviewed by Dr. Christopher Knee, ND
  1. Wellness blog
  2. Research Update: A Systematic Review and Meta-a...
The following article provides a summary of the research conducted by Hawrelak et al. titled Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis, which was published in the journal Complementary Therapies in Medicine in 2020.

Background

Irritable bowel syndrome (IBS) is a functional disorder affecting approximately 11% of the global population. Many factors contribute to the condition including dysfunction of the microbiome-brain-gut axis, inflammation of the gastrointestinal tract, and altered central nervous system activity. While common symptoms of IBS include abdominal pain and discomfort, its presentation can be diverse. Due to the complexity of IBS pathophysiology, limited research exists for assessing the efficacy of treatment for this condition. This article sought to review the efficacy and safety of Western herbal medicine (WHM) for the treatment of IBS.

Methods

This study was a systematic review and meta-analysis of double-blind placebo-controlled trials on WHM. Papers written in languages other than English were translated, and studies were included if patients met IBS diagnosis standards (which have shifted over time) or if patients had clinical symptoms of IBS. Meta-analyses were performed on studies that had two or more trials that included Mentha piperita oil, Aloe vera, and asafoetida. Bias was categorized as either low, high, or unclear based on the Cochrane risk of bias assessment. Improvement of IBS symptoms was left to the author of each article to define, and articles with similar definitions were grouped together for analysis.
peppermint oil in bottle surrounded by peppermint leaves

Oil from Mentha piperita, commonly referred to as peppermint, has been shown to reduce symptoms of IBS.

Results

A total of 1229 articles were retrieved from MEDLINE, EMBASE, and the Cochrane Database, as well as from a hand-search. 33 studies met the inclusion criteria. Of those, 17 investigated Mentha piperita oil, 15 investigated other WHM treatments, and one study investigated both Mentha piperita oil and Pimpinella anisum oil.

In the Aloe vera meta-analysis, 126 subjects were included in the intention to treat (ITT) analysis, 64 of which took the extract, while 62 did not. In the Aloe vera group, 45% of patients experienced improvement in IBS symptoms compared to only 27% in the control group, indicating a 69% greater relative likelihood of improvement in the Aloe vera group versus placebo (RR = 1.69). The number needed to treat (NTT) for one patient to experience symptom relief was six.

In the asafoetida meta-analysis, 133 participants were included in the ITT analysis, 65 of which took the extract, while 68 did not. In the asafoetida group, 63% of patients experienced symptom improvement, while only 37% did in the control group, indicating a 52% greater relative likelihood of improvement in the asafoetida group versus placebo (RR = 1.52). The NNT to improve IBS symptoms was five.

In the Mentha piperita meta-analysis, articles were categorized into two groups: those that evaluated outcome by overall IBS symptom relief and those that defined outcome as solely relief of abdominal pain. In the first group, 684 subjects were included in the study, 351 of which had the Mentha piperita oil and 333 were the control. In the essential oil group, 64% of participants experienced global relief of IBS symptoms compared to only 32% of the control, indicating a 95% greater relative likelihood of symptom improvement compared to placebo (RR = 1.95). The NTT was four in this analysis. In the second group, the 207 participants were included with 103 in the experimental group and 104 in the control. In the Mentha piperita group, 67% experienced relief of abdominal pain compared to only 30% in the control, indicating a 114% relative likelihood of improvement versus placebo (RR = 2.14). In this analysis, the NTT was three.

In general, WHM treatment produced adverse effects similar to those in the control groups with the exception of Capsicum annuum, as 24% of individuals in the Capsicum annuum group experienced severe abdominal pain. The number needed to harm in the Mentha piperita group was 100, and 10 of the 648 participants reported heartburn (1.5%). Only one subject in the asafoetida group reported an adverse event, which was a laxative effect, and the only side effect reported in the Aloe vera analyses was distension in patients with mixed- and diarrhea-type IBS.

Critical analysis

Overall, WHM produced statistically significant benefits in the treatment of IBS. Mentha piperita, Aloe vera, and asafoetida improved IBS symptoms overall, and Mentha piperita specifically led to a relief of abdominal pain. Other WHM treatments that showed statistically significant efficacy included the following: herbal formulas STW 5, STW 5-II, and Carmint; Pimpinella anisum essential oil; Curcuma longa and Foeniculum vulgare essential oil combined; and the herbal blend of Schinopsis lorentzii, Aesculus hippocastanum, and Mentha piperita oil.

Mentha piperita oil produced consistent results with only two outliers out of a total of 18 studies. These two studies failed to replicate positive results; however, this was likely attributable to significant differences in trial design as they were both crossover trials. In general, crossover trials do not evaluate IBS well due to limitations in the ability to establish an adequate washout period between treatment and control. This meta-analysis suggests that Mentha piperita oil is more effective than placebo in improving both general IBS symptoms and abdominal pain with the NNT being four and three, respectively. Mentha piperita oil also has a much better benefit-to-harm ratio compared to other conventional treatments; for example, its ratio is 25, while that of tricyclic antidepressants and alosetron are 2.3 and 2.6, respectively. While its benefit-to-harm ratio was substantially less than rifaximin (25 versus 846), its NNT is substantially favorable (four compared to 11). In fact, its NNT was lower than or equal to other conventional treatments including soluble fiber, antidepressants, and probiotics.

Other herbs and herbal formulas were analyzed in this review which also produced positive results in the treatment of IBS. Herbal formulas STW 5 and STW 5-II both reduced abdominal pain and overall IBS symptoms, while the herbal formula Carmint reduced symptoms of both abdominal pain and bloating. Pimpinella anisum essential oil completely stopped IBS symptoms in 75% of subjects. Quality of life and overall IBS symptoms were improved in the Foeniculum vulgare and Curcuma longa study, and the Schinopsis lorentzii, Aesculus hippocastanum, and Mentha piperita review indicated an improvement of symptoms of bloating and constipation.

More data is needed to evaluate the long-term use of WHM and many herbs, including Aloe vera and asafoetida, would benefit from larger-sized studies.

The bottom line

Many WHM show great potential for the treatment of IBS. Of the current research, Mentha piperita oil stands out due to its low potential for adverse effects, low NNT, and strong replicability of positive outcomes. It is for these reasons that Mentha piperita should be considered as a first line therapy for short-term use in IBS treatment. More studies are needed overall on the effects of WHM herbs, particularly in their use as a long-term therapy.

Simplify the delivery of whole person care

Create free account I'm a patient
References
  1. Hawrelak, J. A., Wohlmuth, H., Pattinson, M., Myers, S. P., Goldenberg, J. Z., Harnett, J., Cooley, K., Van De Venter, C., Reid, R., & Whitten, D. L. (2020). Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Complementary Therapies in Medicine, 48, 102233.

Author

Dr. Clara Sage Sartor, ND, BSc Avatar
Written by Dr. Clara Sage Sartor, ND, BSc
Dr. Christopher Knee, ND
Medically reviewed by Dr. Christopher Knee, ND

Disclaimer

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

SHARE THIS POST
  • Print
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • Pinterest

More resources

Protocols
Practice resources
Ingredient library
Webinars

Make healthcare whole with Fullscript

Join 100,000+ providers building the future of whole person care today.

Create free account

Fullscript content philosophy

At Fullscript, we are committed to curating accurate, and reliable educational content for providers and patients alike. Our educational offerings cover a broad range of topics related to whole person care, such as supplement ingredients, diet, lifestyle, and health conditions.

Medically reviewed by expert practitioners and our internal Medical Advisory Team, all Fullscript content adheres to the following guidelines:

  1. In order to provide unbiased and transparent education, information is based on a research review and obtained from trustworthy sources, such as peer-reviewed articles and government websites. All medical statements are linked to the original reference and all sources of information are disclosed within the article.
  2. Information about supplements is always based on ingredients. No specific products are mentioned or promoted within educational content.
  3. A strict policy against plagiarism is maintained; all our content is unique, curated by our team of writers and editors at Fullscript. Attribution to individual writers and editors is clearly stated in each article.
  4. Resources for patients are intended to be educational and do not replace the relationship between health practitioners and patients. In all content, we clearly recommend that readers refer back to their healthcare practitioners for all health-related questions.
  5. All content is updated on a regular basis to account for new research and industry trends, and the last update date is listed at the top of every article.
  6. Potential conflicts of interest are clearly disclosed.
Learn more

The healthiest cookies you’ll choose today

Our website uses cookies to collect useful information that lets us and our partners support basic functionality, analyze visitor traffic, deliver a better user experience, and provide ads tailored to your interests. Agreeing to the use of cookies is your choice. Learn more

Fullscript leaf icon
Platform
  • What’s new
  • Integrations
  • Testimonials
  • Catalog
Company
  • About us
  • Blog
  • Why Fullscript
  • Careers
  • Partnerships
  • Quality program
Help
  • Book a demo
  • Support Center
  • Provider FAQs
  • Patient FAQ
  • Contact us
  • Security
Developers
  • Engineering at Fullscript
  • API

© Fullscript 2025. All rights reserved.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

  • Privacy Statement
  • Terms of Service
  • Accessibility Policy
  • Customer Support Policy
  • Acceptable Use Policy
  • Privacy Rights Notice
  • Auto Refill Terms and Conditions
  • Consumer Health Data Privacy Notice
American flag - toggles to show american specific contentUS
Canadian flag - toggles to show canada specific contentCanada